Sign in →

Test Code AFP Alpha Feoprotein Tumor Marker

Important Note

Medicare frequency limitations exist for this test in addition to diagnosis requirements. Click on link for list of medically necessary diagnoses: http://www.munsonhealthcare.org/medical-necessity. Click on link for Advance Beneficiary Notice of Noncoverage form: Advance Beneficiary Notice of Noncoverage

EHR Test Codes

  Test Code Test Name
Atlas AFP Alpha Feto Protein Tumor Marker
Cerner   Alpha Fetoprotein Tumor Marker

Specimen Requirements

Preparation of Patient: 

None

 

Container Type: 

Gold Top 6mL SST Gel & Clot Activator Tube

Specimen Type:

Serum

 

Specimen Volume: 

2.5 mL Serum minimum .5 mL

 

Specimen Handling/Transport:

Separate serum from cells within 2 hours of collection.

Transport ambient room temperature.

 

Specimen Stability/Storage:

5 days refrigerated 2-8°C

Performing Laboratory

Munson Medical Center Laboratories

Chemistry Department

Priority, Frequency, & Turnaround

Priority:

Non-Emergent

 

Frequency:

24 hours 7 days a week

 

Turnaround:

0 - 1 days

Methodology

Chemiluminescence

Reporting

Reference Range:

0- 6 ng/mL

 

Interpretive Data:

Testing performed by chemiluminescence on a Beckman Coulter DXI/Access platform. Results may not be comparable with tests performed on other manufacturer's methods or platforms.

 

Critical Decision: 

None

Clinical Significance

AFP is a tumor associated protein.  AFP levels can assist in the prognosis and managment of patients with non-seminomatous testicular carcinoma.  Elevated AFP levels have also been associated with ataxia telangiectasia, hereditary tyrosinemia, neonatal hyperbilirubinemia, acute and chronic viral hepatitis, cirrhosis, and other malignancies.  Therefore, AFP is not recommended as a screening tool for cancer detection in the general population.

CPT Code(s)

82105